62 related articles for article (PubMed ID: 2435131)
1. [Clinical evaluation of CMA in the treatment of prostatic cancer].
Fukuoka H; Goto A; Murai T; Satomi Y; Moriyama M; Senga Y; Shirai K; Nakao H
Hinyokika Kiyo; 1986 Dec; 32(12):1821-30. PubMed ID: 2435131
[TBL] [Abstract][Full Text] [Related]
2. A randomized phase II trial of flutamide vs chlormadinone acetate in previously untreated advanced prostatic cancer. The Japan Flutamide Study Group.
Akaza H; Usami M; Kotake T; Koiso K; Aso Y
Jpn J Clin Oncol; 1993 Jun; 23(3):178-85. PubMed ID: 7688829
[TBL] [Abstract][Full Text] [Related]
3. [Hormonal environment following treatment with a small dose of estrogen--small dose of estrogen alone and in combination with an anti-androgen].
Hayashi T; Taki Y; Ikai K; Hiura M; Kiriyama T
Hinyokika Kiyo; 1987 Jul; 33(7):1035-42. PubMed ID: 2446483
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study on chlormadinone acetate alone followed by combination with LH-RH analogue for prostatic cancer: effects on lipid metabolism].
Shimada M; Uchida H; Kasahara T; Fuji K; Ogawa Y; Yoshida H; Hamajima T; Matsuda N; Ikeuchi T; Kai Y; Hiramori M; Hoshino M; Inoue K; Higaki Y
Hinyokika Kiyo; 1998 Jul; 44(7):525-32. PubMed ID: 9752613
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of disease flare with diethylstilbestrol diphosphate and chlormadinone acetate administration for two weeks prior to slow-releasing leuprolide acetate in prostatic cancer patients.
Ohuchi H; Noguchi K; Kinoshita Y; Hosaka M; Kawasaki C; Miura T; Kondo I; Harada M
Hinyokika Kiyo; 2000 Aug; 46(8):531-6. PubMed ID: 11019371
[TBL] [Abstract][Full Text] [Related]
6. Effects of combination therapy with a luteinizing hormone-releasing hormone agonist and chlormadinone acetate on rat prostate weight and plasma testosterone levels.
Gotanda K; Shinbo A; Okada M; Nakano Y; Kobayashi H; Sasaki T; Hagiwara M; Akaza H
Prostate Cancer Prostatic Dis; 2003; 6(1):66-72. PubMed ID: 12664069
[TBL] [Abstract][Full Text] [Related]
7. [Pretreatment with chlormadinone acetate in prostate cancer patients treated with a luteinizing hormone-releasing hormone analogue].
Yamamoto A; Sumiyoshi Y; Miyake N; Yokozeki H; Kanayama H; Kagawa S
Hinyokika Kiyo; 1998 Aug; 44(8):557-63. PubMed ID: 9783191
[TBL] [Abstract][Full Text] [Related]
8. [Clinical usefulness of chlormadinone acetate as an alternative antiandrogen therapy for prostate cancer relapse after combined androgen blockade therapy].
Ehara H; Katoh S; Nakane K; Katoh T; Takada T; Kojima K; Kamei S; Hagiwara N; Yuhara K; Takahashi Y; Fujimoto Y; Fujihiro S; Kanimoto Y; Deguchi T
Hinyokika Kiyo; 2009 Apr; 55(4):199-203. PubMed ID: 19462824
[TBL] [Abstract][Full Text] [Related]
9. [Hormonal and clinical efficacy of (D-Leu6)-des Gly-NH2(10)-LH.RH ethylamide against prostatic cancer].
Imai K; Kumasaka F; Kobayashi M; Suzuki T; Takahashi O; Yamanaka H
Hinyokika Kiyo; 1985 Dec; 31(12):2302-6. PubMed ID: 2938456
[TBL] [Abstract][Full Text] [Related]
10. Prevention of the initial testosterone surge induced by a luteinizing hormone-releasing hormone analogue in prostate cancer patients: the endocrinological effects of pretreatment with chlormadinone acetate.
Yamamoto A; Sumiyoshi Y; Miyake N; Yokozeki H; Kanayama H; Kagawa S
J Med Invest; 1999 Feb; 46(1-2):55-8. PubMed ID: 10408158
[TBL] [Abstract][Full Text] [Related]
11. [Effects of anti-androgens on sexual function. Double-blind comparative studies on allylestrenol and chlormadinone acetate Part I: Nocturnal penile tumescence monitoring].
Kumamoto Y; Yamaguchi Y; Sato Y; Suzuki R; Tanda H; Kato S; Mori K; Matsumoto H; Maki A; Kadono M
Hinyokika Kiyo; 1990 Feb; 36(2):213-26. PubMed ID: 1693037
[TBL] [Abstract][Full Text] [Related]
12. Antiandrogenic therapy for the treatment of early stage prostatic cancer.
Nishimura R; Shida K
Prostate Suppl; 1981; 1():27-34. PubMed ID: 6176981
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of flutamide, a pure antiandrogen, in prostatic cancer phase II dose-finding study].
Aso Y; Akaza H; Koiso K; Kameyama S; Koyanagi T; Kawai T; Kumamoto Y; Tazaki H; Funyu T; Oshima H
Hinyokika Kiyo; 1993 Apr; 39(4):391-403. PubMed ID: 8503339
[TBL] [Abstract][Full Text] [Related]
14. Radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation: Five-year results.
Homma Y; Akaza H; Okada K; Yokoyama M; Moriyama N; Usami M; Hirao Y; Tsushima T; Sakamoto A; Ohashi Y; Aso Y;
Int J Urol; 2004 May; 11(5):295-303. PubMed ID: 15147545
[TBL] [Abstract][Full Text] [Related]
15. [Conservative therapy of prostate cancer using Turisteron].
Schnorr D; Dörner G; Stahl F; Rohde W; Guddat HM
Z Urol Nephrol; 1987 Mar; 80(3):149-57. PubMed ID: 3111122
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of prostatic cancer with an LH-RH analog].
Fuse H; Zama S; Akimoto S; Shimazaki J; Murakami S; Igarashi T
Hinyokika Kiyo; 1986 Aug; 32(8):1113-9. PubMed ID: 3098063
[TBL] [Abstract][Full Text] [Related]
17. [High-dosage medroxyprogesterone acetate treatment in advanced prostatic cancer].
Flamm J; Spona J
Wien Klin Wochenschr; 1987 Oct; 99(19):682-6. PubMed ID: 2961131
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation.
Mazzei T; Mini E; Eandi M; Reali EF; Fioretto L; Bartoletti R; Rizzo M; Calabrò G; Periti P
Drugs Exp Clin Res; 1989; 15(8):373-87. PubMed ID: 2513176
[TBL] [Abstract][Full Text] [Related]
19. [Effect of estrogen treatment on antithrombin III activity in patients with carcinoma of the prostate].
Hayashi T; Takenawa J; Ryoji O; Hiura M; Taki Y; Kiriyama T
Hinyokika Kiyo; 1989 May; 35(5):807-13. PubMed ID: 2478002
[TBL] [Abstract][Full Text] [Related]
20. [The evaluation of the effect of Estracyt on prostatic cancer].
Fukuoka H; Ishibashi Y; Sakai N; Ogawa T; Satomi Y; Sugawara T; Kamimura H; Yamaguchi T; Kishida K; Shirai K
Hinyokika Kiyo; 1991 Jan; 37(1):91-7. PubMed ID: 2011974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]